|
|
| | HSD17B13-IN-99 Basic information |
| Product Name: | HSD17B13-IN-99 | | Synonyms: | HSD17B13-IN-99;2-Pyridinecarboxamide, N-[3,4-dihydro-3-[2-(2-methoxyphenyl)ethyl]-4-oxo-5-quinazolinyl]-5-hydroxy-6-(trifluoromethyl)- | | CAS: | 2849338-46-9 | | MF: | C24H19F3N4O4 | | MW: | 484.43 | | EINECS: | | | Product Categories: | | | Mol File: | 2849338-46-9.mol |  |
| | HSD17B13-IN-99 Chemical Properties |
| density | 1.42±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 10.50±0.20(predicted) |
| | HSD17B13-IN-99 Usage And Synthesis |
| Uses | HSD17B13-IN-99 (Compound 6) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 value of < 0.1 μM for estradiol. HSD17B13-IN-99 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH, as well as drug-induced liver injury (DILI)[1]. | | References | [1] Joshua Odingo, et al. Hydroxypyridine hsd17b13 inhibitors and uses thereof. U.S., WO2022216626. 2022-10-13. |
| | HSD17B13-IN-99 Preparation Products And Raw materials |
|